Abstract
We aim to study the possible association between tattoo ink exposure and development of certain cancers in the recently established Danish Twin Tattoo Cohort.
Tattoo ink is known to transfer from skin to blood stream and accumulate in regional lymph nodes. We are concerned that tattoo ink induce inflammation at deposit site that may eventually become chronic and increase risk of abnormal cell proliferation, especially skin cancer and lymphoma.
We conducted two designs of study in twins in order to improve confounder control: A cohort study of 2,367 randomly selected twins and a case-control study of 316 twins born in the period 1960-1996. Cancer diagnoses (ICD-10) were retrieved from the Danish Cancer Registry and tattoo ink exposure from the Danish Twin Tattoo survey from 2021. The analysis addressed effects of time-varying exposure.
In the case-control study, individual level analysis resulted in a hazard of skin cancer (of any type except basal cell carcinoma) that was 1.62 times higher among tattooed (95% CI: 1.08-2.41). Twin-matched analysis of 14 twin pairs discordant for tattoo ink exposure and skin cancer show HR=1.33 (95% CI: 0.46-3.84). For skin cancer and lymphoma, increased hazards were found for tattoos larger than the palm of a hand: HR=2.37 (95% CI: 1.11-5.06) and HR=2.73 (95% CI: 1.33-5.60), respectively. In the cohort study design, individual level analysis resulted in a hazard ratio of 3.91 (95% CI: 1.42-10.8) for skin cancer and 2.83 (95% CI: 1.30-6.16) for basal cell carcinoma.
In conclusion, we are very concerned that tattoo ink interacting with surrounding cells may have severe consequences. Further studies are needed beneficial to public health – the sooner the better.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Regional Committees on Health Research and Ethics for Southern Denmark waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the Danish Twin Registry.
